⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL8134374 | 0.97 | ALOX15 (0.36) | — | |
| Hydrochloric Acid SCHEMBL28275439 | 0.97 | ALOX15 (0.36) | — | |
| SCHEMBL27747566 | 0.87 | ALOX15 (0.62) | — | |
| SCHEMBL31391 | 0.81 | — | — | |
| Hydrochloric Acid SCHEMBL30373465 | 0.79 | ALOX15 (0.40) | — | |
| Hydrochloric Acid SCHEMBL30373752 | 0.79 | ALOX15 (0.40) | — | |
| SCHEMBL9517406 | 0.77 | ALOX15 (0.62) | — | |
| SCHEMBL15011631 | 0.75 | DYRK1A (0.38) | — | |
| Pyridine SCHEMBL27834852 | 0.75 | ALDH1A1 (0.41) | — | |
| Pyrimidine SCHEMBL15020699 | 0.72 | ALOX15 (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2686 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12595265-B2 | Inhibitors of activin receptor-like kinase | BLUEPRINT MEDICINES CORPORATION (US) | 2026-04-07 | — | — | US | claimed |
| EP-4463457-B1 | PYRROLO[1,2-B]-2-PYRIDAZINONE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS | SUVEN LIFE SCIENCES LTD (IN) | 2026-02-04 | — | — | EP | claimed |
| EP-4658655-A1 | CONDENSED HETEROCYCLIC COMPOUNDS AS INHIBITOR OF DIACYLGLYCEROL KINASES | Beone Medicines I GmbH (CH) | 2025-12-10 | — | — | EP | claimed |
| US-20250353858-A1 | CONDENSED HETEROCYCLIC COMPOUNDS AS INHIBITOR OF DIACYLGLYCEROL KINASES | BEONE MEDICINES I GMBH (CH) | 2025-11-20 | — | — | US | claimed |
| WO-2024160278-A1 | CONDENSED HETEROCYCLIC COMPOUNDS AS INHIBITOR OF DIACYLGLYCEROL KINASES | BEIGENE, LTD. (KY) | 2024-08-08 | — | — | WO | claimed |
| WO-2024106781-A1 | LIPID COMPOUND AND COMPOSITION FOR DELIVERY OF ACTIVE SUBSTANCE | 한국생명공학연구원 | 2024-05-23 | — | — | WO | claimed |
| US-20240158398-A1 | INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE | BLUEPRINT MEDICINES CORPORATION | 2024-05-16 | — | — | US | claimed |
| EP-3442977-B1 | INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE | BLUEPRINT MEDICINES CORP (US) | 2023-06-28 | — | — | EP | claimed |
| US-11634422-B2 | Inhibitors of activin receptor-like kinase | BLUEPRINT MEDICINES CORPORATION (US) | 2023-04-25 | — | — | US | claimed |
| US-20220315585-A1 | INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE | BLUEPRINT MEDICINES CORPORATION | 2022-10-06 | — | — | US | claimed |
| US-20170107178-A1 | INDOLE DERIVATIVES FOR USE IN MEDICINE | IOMET PHARMA LTD. (GB) | 2017-04-20 | — | — | US | claimed |
| EP-3125883-A1 | INDOLE DERIVATIVES FOR USE IN MEDICINE | Iomet Pharma Ltd. (GB) | 2017-02-08 | — | — | EP | claimed |
| WO-2015150097-A1 | INDOLE DERIVATIVES FOR USE IN MEDICINE | IOMET PHARMA LTD (GB) | 2015-10-08 | — | — | WO | claimed |
| US-20130303563-A1 | TREATMENT OF PERITONEAL INJURY USING JAK INHIBITORS | LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE AT HARBOR-UCLA MEDICAL CENTER | 2013-11-14 | — | — | US | claimed |
| EP-1651647-A1 | NICOTINAMIDE DERIVATIVES USEFUL AS PDEA4 INHIBITORS | Pfizer Limited (GB) | 2006-05-03 | — | — | EP | claimed |
| WO-2005010001-A1 | NICOTINAMIDE DERIVATIVES USEFUL AS PDEA4 INHIBITORS | PFIZER LIMITED (GB) | 2005-02-03 | — | — | WO | claimed |
| US-6472389-B1 | Pyrrolo[1,2-b] pyridazine derivatives having sPLA2 inhibitory effect | SHIONOGI & CO., LTD. (JP) | 2002-10-29 | — | — | US | claimed |
| CN-1302300-A | Pyrrolo [1, 2-b]Pyridazine sPLA2Inhibitors | SHIONOGI & CO (JP) | 2001-07-04 | — | — | CN | claimed |
| EP-1085021-A1 | PYRROLO 1,2-b]PYRIDAZINE DERIVATIVES HAVING sPLA 2? INHIBITORY EFFECT | SHIONOGI & CO., LTD. (JP) | 2001-03-21 | — | — | EP | claimed |
| US-5391468-A | With emulsion layer containing blend of spectrally sensitized tabular iodohalide grains and second, slower, fine grain population of higher solubility silver salt content having second dye adsorbed to surface | EASTMAN KODAK COMPANY (US) | 1995-02-21 | — | — | US | claimed |